about
Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsOptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensOptimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Age-shifting in malaria incidence as a result of induced immunological deficit: a simulation study.Measuring windows of selection for anti-malarial drug treatments.Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug TreatmentQuantifying the pharmacology of antimalarial drug combination therapy.Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials.Reply to "Parasite Strain, Host Immunity, and Circulating Blood Cells with Dead Parasites: Why Predicting Malaria Parasite Clearance Is Not a Simple Task".The Importance of Scientific Debate in the Identification, Containment, and Control of Artemisinin Resistance.Analysing malaria drug trials on a per-individual or per-clone basis: a comparison of methods.Modelling the impact of insecticide-based control interventions on the evolution of insecticide resistance and disease transmissionPhysiologically-based pharmacokinetic model of vaginally administered dapivirine ring and film formulations
P50
Q28534701-D6A047E7-D050-4CAF-B7D2-A3BE2E55D95EQ28831110-D9C5F896-22C8-48B3-AD24-C19E34A13BAEQ33678483-DD1554AF-EC32-4B3A-A645-B24F66E43BAAQ35885315-EAE818A1-CA9E-49A5-8FC6-C3AD05A04F21Q35906652-4C32B3DC-E054-4227-A1DF-12E62C93D694Q36075783-57521E14-6098-426F-A681-72D747851A09Q36076111-047FBC0B-4E0A-49F4-A94D-9AC454E8C309Q36888028-4E4FDE0F-9EB1-4B26-B44A-F3202E4C9AA4Q37283299-26304EE5-9985-45A7-8D50-9EE5FEF4F375Q38225084-8A4C12C9-8520-4115-A4A4-A8E2FB0387A9Q42564004-B29E6083-9357-4AB8-9E3D-AF0F10D2CAE5Q43595043-BCC1EBCF-FA00-4E9F-97C3-99602EB8D4FFQ46865781-FFF5C98B-FCE0-420F-B4BF-8346762C49B7Q58698862-14058852-F50D-4727-B6F0-3E96A3000D5DQ58736449-46CEA54F-9807-4D83-8478-B2610BEA7643
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katherine Kay
@ast
Katherine Kay
@en
Katherine Kay
@es
Katherine Kay
@nl
Katherine Kay
@sl
type
label
Katherine Kay
@ast
Katherine Kay
@en
Katherine Kay
@es
Katherine Kay
@nl
Katherine Kay
@sl
altLabel
Katherine Winter
@en
prefLabel
Katherine Kay
@ast
Katherine Kay
@en
Katherine Kay
@es
Katherine Kay
@nl
Katherine Kay
@sl
P1053
J-1898-2015
P106
P1153
56508083400
P21
P31
P3829
P496
0000-0002-0885-0670